Jiarui Lu
Xi'an, 710038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The ratio of circulating CD56dim NK cells to follicular T helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosis.
Journal: Heliyon
Published: January 23, 2024
Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases.
Journal: Vaccine: X
Published: May 19, 2023
Late-Onset Anti-GABAB Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset Patients.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 08, 2023
Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study.
Journal: Frontiers in immunology
Published: January 20, 2023
Efficacy and safety of repeated low-dose rituximab therapy in relapsing-remitting multiple sclerosis: A retrospective case series study.
Journal: Multiple sclerosis and related disorders
Published: October 19, 2022
Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.
Journal: Frontiers in neurology
Published: January 18, 2022
Association between serum low-density neutrophils and acute-onset and recurrent Guillain-Barré syndrome.
Journal: Brain and behavior
Published: September 05, 2021
Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study.
Journal: BMC neurology
Published: July 20, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026